Using erythritol air polishing to treat peri-implant mucositis
Erythritol Air Polishing in Mucositis Treatment: A Randomized Controlled Trial
NA · University of Coimbra · NCT06455306
This study is testing if using erythritol air polishing can help people with dental implants and gum inflammation feel better compared to just following regular oral hygiene instructions.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | University of Coimbra (other) |
| Locations | 1 site (Coimbra) |
| Trial ID | NCT06455306 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of air polishing systems using erythritol powder compared to standard oral hygiene instructions in treating peri-implant mucositis. Participants aged 18 to 80 with at least one dental implant and diagnosed with peri-implant mucositis will be randomly assigned to one of three groups: one receiving a single application of erythritol air polishing, another receiving monthly applications, and a control group receiving only oral hygiene instructions. The study will assess clinical outcomes at baseline, 3 months, and 6 months post-treatment.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 80 with at least one dental implant affected by peri-implant mucositis.
Not a fit: Patients with uncontrolled systemic diseases, those on certain medications, or those unable to perform oral hygiene measures may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a non-surgical option for effectively managing peri-implant mucositis.
How similar studies have performed: Other studies have shown promising results with air polishing techniques for periodontal conditions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults with at least one implant in function for a minimum of one year affected by peri-implant mucositis. Exclusion Criteria: 1. Pregnant or lactating women 2. patients unable to understand the treatment protocol and sign informed consent and/or patients younger than 18 years old, 3. medical conditions that prevents an oral examination, 4. incapability to perform oral hygiene measures due to physical or mental disorders, 5. patients with uncontrolled systemic diseases or neoplasms, infection with HIV or hepatitis, cardiovascular disease, blood disorders (e.g. coagulation disorders) and severe osteoporosis, 6. patients who have received systemic antibiotics, corticosteroids, or immunosuppressive therapy within 3 months before periodontal evaluation (baseline), as well as those who chronically use nonsteroidal anti-inflammatory drugs, require antibiotic coverage for dental procedures, and those who are undergoing chronic treatment with medications known to affect periodontal health (such as phenytoin or cyclosporine), 7. alcohol or drug addiction 8. implants with mobility and/or occlusal overload.
Where this trial is running
Coimbra
- University of Coimbra — Coimbra, Portugal (RECRUITING)
Study contacts
- Study coordinator: Orlando Martins
- Email: orlmm@yahoo.com
- Phone: 917298190
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Peri-implant Mucositis, peri-implant mucositis, erythritol powder air-polishing, non-surgical treatment